Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

Clinical trial NCT05527717 · RECRUITING

Trial details

NCT number: NCT05527717
Sponsor: Samsung Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiogenic Shock Acute Myocardial Infarction Multi Vessel Coronary Artery Disease Extracorporeal Membrane Oxygenation

Start date: 2022-11-16
Primary completion: 2027-12-31
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.